We are live on
!
Find out more
GIM
Granahan Investment Management Portfolio holdings
AUM
$2.07B
1-Year Est. Return
56.45%
This Fund
S&P 500
This Quarter
Est. Return
-23.11%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$2.93B
AUM Growth
-$1.1B
(-27%)
Cap. Flow
+$25.1M
Cap. Flow
% of AUM
0.86%
Top 10 Holdings %
Top 10 Hldgs %
32.29%
Holding
195
New
17
Increased
84
Reduced
71
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Toast
TOST
|
+$57.5M |
| 2 |
Kornit Digital
KRNT
|
+$34.3M |
| 3 |
Paylocity
PCTY
|
+$33.3M |
| 4 |
FIGS
FIGS
|
+$23.2M |
| 5 |
SI
Silvergate Capital Corporation
SI
|
+$18.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chegg
CHGG
|
+$49.8M |
| 2 |
Evolent Health
EVH
|
+$39.2M |
| 3 |
MSP
Datto Holding Corp.
MSP
|
+$36.9M |
| 4 |
BBBY
Bed Bath & Beyond
BBBY
|
+$35.3M |
| 5 |
GTLS
Chart Industries
GTLS
|
+$19.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.71% |
| 2 | Healthcare | 20.5% |
| 3 | Industrials | 13.17% |
| 4 | Consumer Discretionary | 10.74% |
| 5 | Communication Services | 5.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
American Well
AMWL
$231M
| $7.07M | 0.24% |
81,821
-2,554
| -3% | -$191K |
|
102
Fate Therapeutics
FATE
$322M
| $6.52M | 0.22% |
263,156
+58,211
| +28% | +$1.61M |
|
|
APLS
103
DELISTED
Apellis Pharmaceuticals
APLS
| $6.4M | 0.22% |
141,592
-12,331
| -8% | -$562K |
|
104
Arcus Biosciences
RCUS
$3.66B
| $6.34M | 0.22% |
250,385
+24,335
| +11% | +$596K |
|
105
Ciena
CIEN
$54.9B
| $6.28M | 0.21% |
137,349
+13,017
| +10% | +$675K |
|
106
PAR Technology
PAR
$751M
| $6.07M | 0.21% |
+161,770
| New | +$5.81M |
|
|
HSKA
107
DELISTED
Heska Corp
HSKA
| $6.02M | 0.21% |
63,653
+22,504
| +55% | +$2.43M |
|
108
Kinsale Capital Group
KNSL
$8.4B
| $5.91M | 0.2% |
25,718
-18,951
| -42% | -$4.19M |
|
109
Onto Innovation
ONTO
$14.5B
| $5.9M | 0.2% |
84,546
-1,300
| -2% | -$96.2K |
|
110
PTC
PTC
$16.4B
| $5.83M | 0.2% |
54,865
-900
| -2% | -$97.2K |
|
111
AXT Inc
AXTI
$4.83B
| $5.69M | 0.19% |
971,340
+23,439
| +2% | +$138K |
|
112
Qualys
QLYS
$6.43B
| $5.62M | 0.19% |
44,589
-3,044
| -6% | -$399K |
|
113
Harvard Bioscience
HBIO
$28.8M
| $5.52M | 0.19% |
153,269
+7,594
| +5% | +$343K |
|
114
Revolve Group
RVLV
$1.73B
| $5.5M | 0.19% |
212,240
-169,280
| -44% | -$6.25M |
|
|
AERI
115
DELISTED
Aerie Pharmaceuticals
AERI
| $5.3M | 0.18% |
707,398
-881,546
| -55% | -$6.21M |
|
|
HDSN
116
Hudson Technologies
HDSN
$240M
| $5.26M | 0.18% |
700,896
-550,079
| -44% | -$4.54M |
|
|
BPMC
117
DELISTED
Blueprint Medicines
BPMC
| $5.24M | 0.18% |
103,646
-53,000
| -34% | -$3.1M |
|
118
Organogenesis Holdings
ORGO
$239M
| $4.84M | 0.17% |
991,980
-989,783
| -50% | -$6.09M |
|
119
Portillo's
PTLO
$325M
| $4.77M | 0.16% |
291,710
-37,626
| -11% | -$726K |
|
120
Silicon Laboratories
SLAB
$7.2B
| $4.63M | 0.16% |
33,028
+341
| +1% | +$47.7K |
|
121
Xencor
XNCR
$1.6B
| $4.62M | 0.16% |
168,962
-26,376
| -14% | -$651K |
|
122
InMode
INMD
$873M
| $4.54M | 0.16% |
202,579
-270,599
| -57% | -$7.11M |
|
123
Harmonic Inc
HLIT
$1.26B
| $4.48M | 0.15% |
516,471
+52,503
| +11% | +$473K |
|
124
Littelfuse
LFUS
$11.6B
| $4.36M | 0.15% |
+17,144
| New | +$4.3M |
|
125
AtriCure
ATRC
$2.12B
| $4.34M | 0.15% |
106,271
+7,660
| +8% | +$363K |
|
Similar funds
BC
AG
TA
ACP
TP
NSUP
ACG
CL
Granahan Investment Management's Q2 2022 Portfolio in Review
As of Q2 2022, Granahan Investment Management held 195 positions worth $2.93B, down 27% from $4.03B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Granahan Investment Management's Q2 2022 filing shows 17 new, 84 increased, 71 reduced and 23 closed positions. Its largest new stake was Toast: 3,468,530 shares worth $44.9M. The largest sale was Chegg, an estimated $49.8M.
By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 35% a quarter earlier, followed by Healthcare and Industrials.
- Granahan Investment Management's largest Q2 2022 buy was Toast: 3,468,530 shares worth $44.9M.
- Granahan Investment Management added most to Kornit Digital in Q2 2022, an estimated $34.3M increase.
- Granahan Investment Management's biggest Q2 2022 reduction was Chegg, cutting an estimated $49.8M.
- Granahan Investment Management fully exited Datto Holding Corp. in Q2 2022, selling an estimated $36.9M.
- Granahan Investment Management's ten largest holdings make up 32% of its $2.93B portfolio in Q2 2022.
- Granahan Investment Management opened 17 new positions and closed 23 in Q2 2022.
- Granahan Investment Management's portfolio value fell 27% quarter-over-quarter to $2.93B.
Based on Granahan Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.